EP0005849B2 - Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides - Google Patents
Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides Download PDFInfo
- Publication number
- EP0005849B2 EP0005849B2 EP79101725A EP79101725A EP0005849B2 EP 0005849 B2 EP0005849 B2 EP 0005849B2 EP 79101725 A EP79101725 A EP 79101725A EP 79101725 A EP79101725 A EP 79101725A EP 0005849 B2 EP0005849 B2 EP 0005849B2
- Authority
- EP
- European Patent Office
- Prior art keywords
- acetoacetamides
- weight
- reaction
- water
- monoalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000000034 method Methods 0.000 claims description 32
- 238000006243 chemical reaction Methods 0.000 claims description 27
- 230000008569 process Effects 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 16
- 239000000460 chlorine Substances 0.000 claims description 16
- 229910052801 chlorine Inorganic materials 0.000 claims description 16
- 239000002904 solvent Substances 0.000 claims description 9
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 8
- 239000004202 carbamide Substances 0.000 claims description 8
- GCPWJFKTWGFEHH-UHFFFAOYSA-N acetoacetamide Chemical compound CC(=O)CC(N)=O GCPWJFKTWGFEHH-UHFFFAOYSA-N 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000012429 reaction media Substances 0.000 claims description 6
- 238000007710 freezing Methods 0.000 claims description 4
- 230000008014 freezing Effects 0.000 claims description 4
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000007791 liquid phase Substances 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 2
- 150000001805 chlorine compounds Chemical class 0.000 claims description 2
- 239000011777 magnesium Substances 0.000 claims description 2
- 229910052749 magnesium Inorganic materials 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 238000005660 chlorination reaction Methods 0.000 description 16
- ATWLCPHWYPSRBQ-UHFFFAOYSA-N N-Methylacetoacetamide Chemical compound CNC(=O)CC(C)=O ATWLCPHWYPSRBQ-UHFFFAOYSA-N 0.000 description 15
- 101001114654 Homo sapiens Methylmalonic aciduria type A protein, mitochondrial Proteins 0.000 description 13
- 102100023377 Methylmalonic aciduria type A protein, mitochondrial Human genes 0.000 description 13
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000004821 distillation Methods 0.000 description 4
- 239000000376 reactant Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- XIWMZCRVSYHMER-UHFFFAOYSA-N 2-chloro-n-methyl-3-oxobutanamide Chemical compound CNC(=O)C(Cl)C(C)=O XIWMZCRVSYHMER-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- FUSJRPBAYJMLEA-UHFFFAOYSA-N 2,2-dichloro-n-methyl-3-oxobutanamide Chemical compound CNC(=O)C(Cl)(Cl)C(C)=O FUSJRPBAYJMLEA-UHFFFAOYSA-N 0.000 description 2
- AOOLFYMBFIGYDE-UHFFFAOYSA-N 2-chloro-3-oxobutanamide Chemical class CC(=O)C(Cl)C(N)=O AOOLFYMBFIGYDE-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- VXNINNWMDGTACV-UHFFFAOYSA-N 3-oxo-n-propylbutanamide Chemical class CCCNC(=O)CC(C)=O VXNINNWMDGTACV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- PMDCZENCAXMSOU-UHFFFAOYSA-N N-ethylacetamide Chemical compound CCNC(C)=O PMDCZENCAXMSOU-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- GUGRBFQNXVKOGR-UHFFFAOYSA-N butyl hypochlorite Chemical compound CCCCOCl GUGRBFQNXVKOGR-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000012320 chlorinating reagent Substances 0.000 description 1
- RMXVHZFHSKRNJN-UHFFFAOYSA-N chlorourea Chemical compound NC(=O)NCl RMXVHZFHSKRNJN-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005695 dehalogenation reaction Methods 0.000 description 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- YPEWWOUWRRQBAX-UHFFFAOYSA-N n,n-dimethyl-3-oxobutanamide Chemical compound CN(C)C(=O)CC(C)=O YPEWWOUWRRQBAX-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
Definitions
- a-Chloro-N-monoalkyl-acetoacetamides are valuable intermediates for the production of insecticides based on phosphoric acid esters, in particular dialkyl phosphates of N-monoalkyl-3-hydroxycrotonic acid amide (cf. US Pat. No. 2,802,855).
- Example 1 90% of a-chloro-N-methylacetoacetamide in addition to 5% of a, a-dichloro-N-methylacetoacetamide and 1.6% of unreacted starting material are obtained under these conditions.
- This DE-OS therefore conveys the teaching that the chlorination of acetoacetamides, in particular of N-monomethylacetoacetamide, only in dilution with an alkanol, the water content of which must not exceed 20%, at temperatures below -15 ° C. to form the corresponding a-monochloro derivatives with a conversion of over 95% and a selectivity of the same order of magnitude in acceptable reaction times, that is, can be carried out within about 2 hours. Any change in these reaction conditions, in particular an increase in the water content in the specified solvent, is associated with a reduction in the conversion and / or the selectivity, it being expressly pointed out that the reaction time also increases with increasing water content. The application of this method is therefore limited in practice. In addition, additional measures for removing the alkanol by distillation are required before the reaction product can be worked up in a known manner.
- the invention is therefore based on the object of a simplified process for the preparation of alpha-chloro-N-monmoalkylacetoacetamides of the general formula wherein R, alkyl radical having 1 to 3 carbon atoms, by reacting N-monoalkyl-acetoacetamides of the general formula where R, which has the meaning given, is to be made available with chlorine in the presence of water-containing solvents at temperatures below 0 ° C., which guarantees a high selectivity of at least 97% with a conversion of at least 95%, without the need for expensive measures, such as the activation of an additional distillation stage to remove solvent, the regulation of the rate of chlorine introduction or the use of urea.
- N-monoalkyl-acetoacetamides and chlorine are used in a molar ratio of 1: 0.8 to 0.95, only water is used as the reaction medium and the reaction in the liquid phase at temperatures in the range from -1 ° C. to -25 ° C in the presence of an inorganic salt, which is added to the starting mixture in the amount necessary for lowering the freezing point to the reaction temperature, the use of urea being excluded.
- the N-monoalkylacetoacetamides can be used as starting products either in pure form or in the form of concentrated aqueous solutions.
- N-monoalkylacetoacetamides are N-methyl, N-ethyl, N-isopropyl and N-n-propylacetoacetamides, with N-methyl and N-ethyl acetoamide being preferred.
- the reactants that is N-monoalkylacetoacetamides and chlorine, are by definition used in a molar ratio of 1: 0.8 to 0.95, preferably up to 0.90. An excess of chlorine should be avoided as this will already have a negative effect on the selectivity.
- the process according to the invention can be carried out discontinuously or continuously at temperatures in the range from -1 ° C to -25 ° C, temperatures in the range from -18 ° C to -23 ° C having proven particularly useful.
- the decisive measure when carrying out the process according to the invention is that only water is used as the reaction medium.
- the amount of an inorganic salt required to lower the freezing point to the reaction temperature is added to the starting mixture, the chlorides of sodium, calcium and / or magnesium having proven particularly useful.
- other inorganic salts which are inert towards the reactants such as KH 2 P0 4 or K 2 HP0 4 .
- good mixing of the reactants can be ensured by mechanical movement.
- the amount of water required to carry out the process according to the invention can be varied within a wide range depending on the solubility of the reactants and the inorganic salt additives present in the reaction.
- at least 0.5 part by weight of water is necessary per part by weight of acetoacetamide used.
- up to 15 parts by weight of water per part by weight of acetoacetamide can also be used.
- Process-technical reasons are decisive for the upper limit, since it is known that a small reaction volume is advantageous in order to achieve a good space / time yield.
- 0.7 to 7 parts by weight of water are used per part by weight of acetoacetamide.
- the reaction mixture is worked up in a known manner, that is, the reaction products are separated from the aqueous phase by extraction with a water-immiscible organic solvent, such as benzene, toluene or chloroform.
- a water-immiscible organic solvent such as benzene, toluene or chloroform.
- a neutralization of the organic phase is not necessary here, but this can be processed further without additional measures, that is, after the extractant and the hydrogen chloride formed during the chlorination have been distilled off, the desired alpha-chloroacetoacetamide remains as a residue.
- alpha-chloro-monoalkylacetoacetamides with a selectivity of up to 99.5% with a conversion of over 95.5% and in a yield of up to 95.5% of theory, based on converted mono-N- alkylacetoacetamide are produced, which was not possible by the previously known methods.
- This result must be rated as surprising, particularly in view of the fact that it has previously been assumed that increasing the amount of water in a reaction medium containing alkanol results in a reduction in selectivity and conversion.
- the apparatus used for the chlorination consisted of an enamelled reaction stirrer with an inlet tube, cooling jacket and bottom outlet, which was connected to a sight glass to separate the layers.
- aqueous phase was fed to chlorination 5 times. A total of 492 parts by weight. N-methylacetoacetamide (MMAA) 99.5% and 283.5% by weight. Chlorine used and a total of 588.6 parts by weight. Obtained 97.4% N-methyl-a-chloroacetoacetamide (MMCAA), that is 96.8% of theory based on implemented MMAA.
- MMAA N-methylacetoacetamide
- MMCAA N-methyl-a-chloroacetoacetamide
- the MMCAA still has 11.8 parts by weight.
- MMAA included.
- the MMAA conversion was 95.6% and the selectivity 99.5%.
- Practically the same results were obtained if instead of NaCl 203 parts by weight.
- CaC1 2 or 163 parts by weight MgCl 2 were used.
- Example 1 The procedure according to Example 1 was repeated, but with the modification that instead of 99.5% N-methylacetoacetamide, an aqueous 68.7% solution was used, which was prepared by reacting diketene with aqueous 40% methylamine had been.
- MMAA N-methylacetoacetamide solution
- MMCAA N-Methyl-a-chloroacetoacetamide
- Example 1 The process according to Example 1 was repeated, but with the modification that after the chlorination had ended, the reaction mixture was cooled and the suspension was filtered, the resulting solid was extracted with benzene and the extract was further treated as indicated in Example 1.
- the residue was 309.4 parts by weight. a melt solidifying at 80 ° C., which was pure 99.5% N-methyl-2-chloroacetoacetamide (MMCAA), that is 52% of theory based on converted MMAA.
- MMCAA N-methyl-2-chloroacetoacetamide
- the remaining mother liquor was worked up as described in Example 1, and from it a further 260 parts by weight. MMCAA 100% calculated, received.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
a-Chlor-N-monoalkyl-acetoacetamide sind wertvolle Zwischenprodukte für die Herstellung von Insektiziden auf Grundlage von Phosphorsäureestern, insbesondere von Dialkylphosphaten der N-Monoalkyl-3-hydroxycrotonsäureami- de (vgl. U.S.-PS 2 802 855).a-Chloro-N-monoalkyl-acetoacetamides are valuable intermediates for the production of insecticides based on phosphoric acid esters, in particular dialkyl phosphates of N-monoalkyl-3-hydroxycrotonic acid amide (cf. US Pat. No. 2,802,855).
Die Herstellung der a-Chloracetoacetamide erfolgte bisher durch Chlorierung der entsprechenden Acetoacetamide, wobei als Nebenprodukte jeweils beträchtliche Mengen der a,a-Dichlor- acetoacetamide gebildet wurden, deren Abtrennung aber aufgrund ähnlicher physikalischer Eigenschaften praktisch nicht möglich ist. Es sind daher bereits mehrere Verfahren bekannt geworden, die durch eine anschliessende selektive Dehalogenierung der a,a-Dichloracetoacetamide zu praktisch reinen a-Chloracetoacetamiden führen. Derartige Verfahren erfordern jedoch zusätzliche Massnahmen und sind daher mit einem unwirtschaftlich hohen Aufwand verbunden.The a-chloroacetoacetamides have hitherto been produced by chlorination of the corresponding acetoacetamides, considerable amounts of the a, a-dichloro-acetoacetamides being formed as by-products, but their separation is practically impossible because of similar physical properties. Several processes have therefore become known which lead to practically pure α-chloroacetoacetamides by subsequent selective dehalogenation of the α, α-dichloroacetoacetamides. However, such methods require additional measures and are therefore uneconomically expensive.
Nachdem in der DE-PS 1493022 (die der U.S.-PS 3 449 421 entspricht) beschriebenen Verfahren, das auf die Herstellung von a-Chlor-N,N-dialkylacetoacetamiden eingeschränkt ist, kann die Chlorierung der N,N-Dialkylacetoacetamide mit unterchloriger Säure, N-Chlorharnstoff und/ oder tert. Butylhypochlorit bei Temperaturen von 0°C bis 80°C durchgeführt werden. Hierbei wird Wasser als geeignetes Lösungsmittel empfohlen, insbesondere dann, wenn als Chlorierungsmittel unterchlorige Säure, die in situ durch Reaktion von Chlor mit Wasser hergestellt werden kann, verwendet wird. Da die Reaktion im unteren Temperaturbereich zu langsam verläuft, wird das Verfahren vorteilhaft bei Raumtemperatur und darüber durchgeführt, wobei durch Mitverwendung von Harnstoff die Selektivität verbessert wird. Wie aus Beispiel 2 ersichtlich, werden unter diesen Bedingungen 96,4% a-Chlor-N,N-dimethyl- acetoacetamid neben 0,6% a,a-Dichlor-N,N-di- methylacetoacetamid und 1,1% N-N-Dimethylacetoacetamid (unumgesetztes Ausgangsmaterial) erhalten, was einer Umwandlung von 92,6% entspricht.After the process described in DE-PS 1493022 (which corresponds to US Pat. No. 3,449,421), which is restricted to the production of a-chloro-N, N-dialkylacetoacetamides, the chlorination of the N, N-dialkylacetoacetamides with hypochlorous acid can , N-chlorourea and / or tert. Butyl hypochlorite can be carried out at temperatures from 0 ° C to 80 ° C. Water is recommended as a suitable solvent, especially if hypochlorous acid, which can be prepared in situ by the reaction of chlorine with water, is used as the chlorinating agent. Since the reaction in the lower temperature range is too slow, the process is advantageously carried out at room temperature and above, the selectivity being improved by the use of urea. As can be seen from Example 2, 96.4% of a-chloro-N, N-dimethyl-acetoacetamide in addition to 0.6% of a, a-dichloro-N, N-dimethylacetoacetamide and 1.1% of NN- Obtained dimethylacetoacetamide (unreacted starting material), which corresponds to a conversion of 92.6%.
Die Übertragung dieses Verfahrens auf die Herstellung von a-Chlor-N-monalkylacetoacetamiden, wie a-Chlor-N-methyl-acetoacetamid war indessen nicht möglich ohne die Bildung von grossen Mengen des entsprechenden a,a-Dichlor-N-methyl-acetoacetamids. Aus der DE-PS 1 618 207 (die der U.S.-PS 3 483 252 entspricht) ist daher ein Verfahren bekannt geworden, nach dem N-Monoalkylacetoacetamide bei Temperaturen unter 0°C, das heisst, im Bereich von -8°C bis -25°C in Gegenwart von Wasser und Harnstoff chloriert werden und wobei zusätzlich die Gegenwart eines Alkohols erforderlich ist. Wie aus Beispiel 1 ersichtlich, werden unter diesen Bedingungen 90% a-Chlor-N-methylacetoacetamid neben 5% a,a-Dichlor-N-methylacetoacetamid und 1,6% unumgesetztes Ausgangsmaterial erhalten.However, the transfer of this process to the production of a-chloro-N-monalkylacetoacetamides, such as a-chloro-N-methyl-acetoacetamide, was not possible without the formation of large amounts of the corresponding a, a-dichloro-N-methyl-acetoacetamide. From DE-PS 1 618 207 (which corresponds to US Pat. No. 3,483,252) a method has therefore become known by which N-monoalkylacetoacetamides are used at temperatures below 0 ° C., that is, in the range from -8 ° C. to - 25 ° C are chlorinated in the presence of water and urea and the presence of an alcohol is additionally required. As can be seen from Example 1, 90% of a-chloro-N-methylacetoacetamide in addition to 5% of a, a-dichloro-N-methylacetoacetamide and 1.6% of unreacted starting material are obtained under these conditions.
Aber auch dieses Verfahren konnte bei Übertragung in den grosstechnischen Bereich nicht befriedigen, da die Menge der als unerwünschte Nebenprodukte gebildeten a,a-Dichlorverbin- dungen noch immer zu gross ist und die benötigten grossen Harnstoffmengen (0,5 Mol je Mol eingesetztes Chlor) in hohem Masse unwirtschaftlich sind.However, even this process was unsatisfactory when it was transferred to the large-scale sector, since the amount of a, a-dichloro compounds formed as undesired by-products is still too great and the large amounts of urea required (0.5 mol per mole of chlorine used) are in are highly uneconomical.
Nach dem in der DE-OS 2049045 (die der NL-Anmeldung 7014636 entspricht) beschirebenen Verfahren soll es hingegen möglich sein, sowohl N-Monoalkyl- als auch N,N-Dialkylacetoacetami- de bei Temperaturen unter 0°C ohne Harnstoffzusatz zu chlorieren, wenn als Lösungsmittel ein Alkanol mit 1 bis 6 C-Atomen verwendet wird, das gegebenenfalls mit 5 bis 40% Wasser, vorzugsweise etwa 15 bis 20% Wasser enthält. Die Selektivität dieses Verfahrens in bezug auf die Bildung der gewünschten a-Monochlorderivate soll gegenüber den bisher bekannten Verfahren erhöht sein, da nur etwa 5% der a,a-Dichlorderivate gebildet werden, die gegebenenfalls nach Entfernen des Alkanols in bekannter Weise durch Behandeln mit einem Reduktionsmittel selektiv dehalogeniert werden können. Wie aus den Beispielen hervorgeht, die sich ausschliesslich mit der Chlorierung von N-Monomethylacetoacetamid befassen, wurden die besten Ergebnisse hinsichtlich Umsatz und Selektivität mit Äthanol als Lösungsmittel erreicht, das 7,4% Wasser enthielt. Eine Erhöhung des Wassergehaltes auf 50% oder gar 75% hatte indessen unter sonst nahezu gleichen Bedingungen ein deutliches Absinken des Umsatzes und der Selektivität zur Folge. Diese DE-OS vermittelt daher die Lehre, dass die Chlorierung von Acetoacetamiden, insbesondere von N-Monomethylacetoacetamid nur in Verdünnung mit einem Alkanol, dessen Wassergehalt 20% nicht übersteigen darf, bei Temperaturen unterhalb von -15°C unter Bildung der entsprechenden a-Monochlorderivate mit einem Umsatz von über 95% und einer Selektivität in der gleichen Grössenordnung in annehmbaren Reaktionszeiten, dass heisst, innerhalb von etwa 2 Stunden durchgeführt werden kann. Jede Veränderung dieser Reaktionsbedingungen, insbesondere die Erhöhung des Wassergehalts im vorgegebenen Lösungsmittel ist mit einer Verminderung des Umsatzes und/oder der Selektivität verbunden, wobei ausdrücklich darauf hingewiesen wird, dass mit steigendem Wassergehalt auch die Reaktionszeit zunimmt. Der Anwendung dieses Verfahrens sind daher in der Praxis enge Grenzen gesetzt. Ausserdem sind zusätzlich Massnahmen zur destillativen Entfernung des Alkanols erforderlich, bevor die Aufarbeitung des Reaktionsproduktes in bekannter Weise vorgenommen werden kann.However, according to the process described in DE-OS 2049045 (which corresponds to NL application 7014636), it should be possible to chlorinate both N-monoalkyl and N, N-dialkylacetoacetamides at temperatures below 0 ° C. without addition of urea, if an alkanol with 1 to 6 carbon atoms is used as solvent, which optionally contains 5 to 40% water, preferably about 15 to 20% water. The selectivity of this process with respect to the formation of the desired a-monochloro derivatives is said to be increased compared to the previously known processes, since only about 5% of the a, a-dichloro derivatives are formed, which if necessary after removal of the alkanol in a known manner by treatment with a Reductants can be selectively dehalogenated. As can be seen from the examples, which deal exclusively with the chlorination of N-monomethylacetoacetamide, the best results in terms of conversion and selectivity were achieved with ethanol as the solvent, which contained 7.4% of water. However, an increase in the water content to 50% or even 75%, under otherwise almost identical conditions, resulted in a significant decrease in turnover and selectivity. This DE-OS therefore conveys the teaching that the chlorination of acetoacetamides, in particular of N-monomethylacetoacetamide, only in dilution with an alkanol, the water content of which must not exceed 20%, at temperatures below -15 ° C. to form the corresponding a-monochloro derivatives with a conversion of over 95% and a selectivity of the same order of magnitude in acceptable reaction times, that is, can be carried out within about 2 hours. Any change in these reaction conditions, in particular an increase in the water content in the specified solvent, is associated with a reduction in the conversion and / or the selectivity, it being expressly pointed out that the reaction time also increases with increasing water content. The application of this method is therefore limited in practice. In addition, additional measures for removing the alkanol by distillation are required before the reaction product can be worked up in a known manner.
Diese engen Grenzen wurden offensichtlich von der Anmelderin selbst erkannt, wie aus den Ausführungen zum Stand der Technik in der U.S.-PS 3 917 694 hervorgeht, worin darauf hingewiesen wird, dass bei diesem Verfahren Umstz und Selektivität in vielen Fällen die Neigung haben abzunehmen, wenn die Reaktion in vergrössertem Massstab durchgeführt wird. In dieser US-PS wird daher das Verfahren zur Chlorierung von N-Alkyl- oder N,N-Dialkylacetoacetamiden bei Temperaturen unter 0°C und einem Alkanol als Lösungsmittel dadurch abgewandelt, dass die Chloreinleitungsgeschwindigkeit bei Beginn begrenzt und mit fortschreitender Reaktion zunehmend gesteigert wird. Hierdurch soll eine gleichbleibende hohe Umwandlung und Selektivität erzielt werden. Wie aus den Beispielen ersichtlich, werden jedoch im Falle der Chlorierung von N-Monomethylacetoacetamid gute Ergebnisse nur dann erreicht, wenn gleichzeitig Harnstoff und zwar in Mengen von bis zu 1 Mol je Mol eingesetztes N-Monomethylacetoacetamid mitverwendet werden, dessen Bezeichnung als «Chlorierungskatalysator» aufgrund dieser grossen Menge nicht mehr gerechtfertigt ist.These narrow limits have obviously been recognized by the applicant itself, as can be seen from the state of the art in US Pat. No. 3,917,694, which indicates that in this process, turnover and selectivity tend to decrease in many cases when the reaction is carried out on an enlarged scale. In this US-PS therefore modifies the process for the chlorination of N-alkyl- or N, N-dialkylacetoacetamides at temperatures below 0 ° C. and an alkanol as solvent by limiting the rate of chlorine introduction at the beginning and increasing progressively as the reaction proceeds. This is intended to achieve a constant high conversion and selectivity. As can be seen from the examples, however, good results are only achieved in the chlorination of N-monomethylacetoacetamide if urea is used at the same time, namely in amounts of up to 1 mol per mole of N-monomethylacetoacetamide used, the name of which is called the “chlorination catalyst” this large amount is no longer justified.
Diese bekannten Verfahren beweisen, dass bei der Chlorierung von Acetoacetamiden mit Chlor die Selektivität in bezug auf die gewünschte Bildung der entsprechenden Monochlorverbindungen durch Senken der Reaktionstemperatur, Auswahl des Lösungsmittels und/oder Verlangsamung der Chloreinleitungsgeschwindigkeit positiv beeinflusst werden kann. Die Erzielung einer hohen Selektivität ist indessen in der Praxis nur dann sinnvoll, wenn sie nicht auf Kosten einer unvollständigen Umsetzung erkauft werden muss. Hohe Selektivität bei gleichzeitig hohem Umsatz können aber nach den bisher bekannten Verfahren, insbesondere bei der Chlorierung von N-Monoalkylacetoacetamiden, die hinsichtlich der unerwünschten Bildung von alpha,alpha-Dichlor- verbindungen ungleich empfindlicher reagieren, als die entsprechenden N,N-Dialkylacetoaceta- mide, nur durch aufwendige Massnahmen erreicht werden.These known processes prove that the chlorination of acetoacetamides with chlorine can have a positive influence on the selectivity with regard to the desired formation of the corresponding monochloro compounds by lowering the reaction temperature, selecting the solvent and / or slowing down the rate of chlorine introduction. Achieving high selectivity, however, only makes sense in practice if it does not have to be purchased at the expense of incomplete implementation. However, high selectivity combined with high conversion can be achieved by the processes known hitherto, in particular in the chlorination of N-monoalkylacetoacetamides, which are more sensitive than the corresponding N, N-dialkylacetoacetamides with regard to the undesired formation of alpha, alpha-dichloro compounds , can only be achieved through elaborate measures.
Der Erfindung liegt daher die Aufgabe zugrunde, ein vereinfachtes Verfahren zur Herstellung von alpha-Chlor-N-monmoalkylacetoacetamiden der allgemeinen Formel
Diese Aufgabe wird erfindungsgemäss dadurch gelöst, dass N-Monoalkyl-acetoacetamide und Chlor im Molverhältnis 1:0,8 bis 0,95 eingesetzt werden, als Reaktionsmedium ausschliesslich Wasser verwendet und die Umsetzung in flüssiger Phase bei Temperaturen im Bereich von -1°C bis -25°C in Gegenwart eines anorganischen Salzes, das dem Ausgangsgemisch in der zur Gefrierpunktserniedrigung auf die Reaktionstemperatur erforderlichen Menge zugegeben wird, durchgeführt wird, wobei die Mitverwendung von Harnstoff ausgeschlossen ist.This object is achieved according to the invention in that N-monoalkyl-acetoacetamides and chlorine are used in a molar ratio of 1: 0.8 to 0.95, only water is used as the reaction medium and the reaction in the liquid phase at temperatures in the range from -1 ° C. to -25 ° C in the presence of an inorganic salt, which is added to the starting mixture in the amount necessary for lowering the freezing point to the reaction temperature, the use of urea being excluded.
Bei dem erfindungsgemässen Verfahren können als Ausgangsprodukte die N-Monoalkylacetoacetamide entweder in reiner Form oder in Form konzentrierter wässriger Lösungen eingesetzt werden.In the process according to the invention, the N-monoalkylacetoacetamides can be used as starting products either in pure form or in the form of concentrated aqueous solutions.
Beispiele für N-Monoalkylacetoacetamide sind N-Methyl, N-Ethyl, N-Isopropyl- und N-n-Propylacetoacetamide, wobei N-Methyl- und N-Ethylacetoamid bevorzugt sind.Examples of N-monoalkylacetoacetamides are N-methyl, N-ethyl, N-isopropyl and N-n-propylacetoacetamides, with N-methyl and N-ethyl acetoamide being preferred.
Die Reaktionsteilnehmer, das sind N-Monoalkylacetoacetamide und Chlor, werden definitionsgemäss im Molverhältnis von 1:0,8 bis 0,95, vorzugsweise bis zu 0,90, eingesetzt. Ein Chlor- überschuss ist zu vermeiden, da hierdurch bereits die Selektivität störend beeinflusst wird.The reactants, that is N-monoalkylacetoacetamides and chlorine, are by definition used in a molar ratio of 1: 0.8 to 0.95, preferably up to 0.90. An excess of chlorine should be avoided as this will already have a negative effect on the selectivity.
Das erfindungsgemässe Verfahren kann bei Temperaturen im Bereich von -1°C bis -25°C diskontinuierlich oder kontinuierlich durchgeführt werden, wobei sich Temperaturen im Bereich von -18°C bis -23°C besonders bewährt haben.The process according to the invention can be carried out discontinuously or continuously at temperatures in the range from -1 ° C to -25 ° C, temperatures in the range from -18 ° C to -23 ° C having proven particularly useful.
Die entscheidende Massnahme bei der Durchführung des erfindungsgemässen Verfahrens besteht darin, dass als Reaktionsmedium ausschliesslich Wasser verwendet wird. Um sicher zu stellen, dass die Umsetzung auch im tieferen Temperaturbereich in flüssiger Phase erfolgt, wird dem Ausgangsgemisch die zur Gefrierpunktserniedrigung auf die Reaktionstemperatur erforderliche Menge eines anorganischen Salzes zugegeben, wobei sich die Chloride von Natrium, Calcium und/oder Magnesium besonders bewährt haben. Es können jedoch auch andere anorganische Salze, die sich gegenüber den Reaktionspartnern inert verhalten, wie KH2P04 oder K2HP04 verwendet werden. Zusätzlich kann durch mechanische Bewegung für eine gute Durchmischung der Reaktionspartner gesorgt werden.The decisive measure when carrying out the process according to the invention is that only water is used as the reaction medium. To ensure that the reaction also takes place in the lower temperature range in the liquid phase, the amount of an inorganic salt required to lower the freezing point to the reaction temperature is added to the starting mixture, the chlorides of sodium, calcium and / or magnesium having proven particularly useful. However, it is also possible to use other inorganic salts which are inert towards the reactants, such as KH 2 P0 4 or K 2 HP0 4 . In addition, good mixing of the reactants can be ensured by mechanical movement.
Die zur Durchführung des erfindungsgemässen Verfahrens erforderliche Wassermenge kann in weitem Bereich variiert werden in Abhängigkeit von der Löslichkeit der Reaktionspartner und der vorhandenen reaktionsinerten anorganischen Salzzusätze. Je Gewichtsteil eingesetztes Acetoacetamid sind jedoch mindestens 0,5 Gewichtsteile Wasser notwendig. Es können jedoch auch bis zu 15 Gewichtsteile Wasser je Gewichtsteil Acetoacetamid eingesetzt werden. Für die obere Grenze sind in erster Linie verfahrenstechnische Gründe massgebend, da bekanntlich zur Erzielung einer guten Raum/Zeitausbeute ein geringes Reaktionsvolumen vorteilhaft ist. Vorzugsweise werden je Gewichtsteil Acetoacetamid 0,7 bis 7 Gewichtsteile Wasser verwendet.The amount of water required to carry out the process according to the invention can be varied within a wide range depending on the solubility of the reactants and the inorganic salt additives present in the reaction. However, at least 0.5 part by weight of water is necessary per part by weight of acetoacetamide used. However, up to 15 parts by weight of water per part by weight of acetoacetamide can also be used. Process-technical reasons are decisive for the upper limit, since it is known that a small reaction volume is advantageous in order to achieve a good space / time yield. Preferably 0.7 to 7 parts by weight of water are used per part by weight of acetoacetamide.
Nach beendeter Chlorierung wird das Reaktionsgemisch in bekannter Weise aufgearbeitet, das heisst, die Reaktionsprodukte werden aus der wässrigen Phase durch Extraktion mit einem mit Wasser nicht mischbaren organischen Lösungsmittel, wie Benzol, Toluol oder Chloroform abgetrennt. Eine Neutralisation der organischen Phase ist hierbei nicht erforderlich, sondern diese kann ohne zusätzliche Massnahmen weiter verarbeitet werden, das heisst, nach Abdestillieren des Extraktionsmittels und des bei der Chlorierung gebildeten Chlorwasserstoffs verbleibt als Rückstand das gewünschte alpha-Chloracetoacetamid.After the chlorination has ended, the reaction mixture is worked up in a known manner, that is, the reaction products are separated from the aqueous phase by extraction with a water-immiscible organic solvent, such as benzene, toluene or chloroform. A neutralization of the organic phase is not necessary here, but this can be processed further without additional measures, that is, after the extractant and the hydrogen chloride formed during the chlorination have been distilled off, the desired alpha-chloroacetoacetamide remains as a residue.
Eine Neutralisation der wässrigen Phase ist hingegen nur dann erforderlich, wenn das Verfahren kontinuierlich durchgeführt wird und die wässrige Phase erneut als Reaktionsmedium für die Chlorierung eingesetzt, das heisst, im Kreislauf geführt wird, da hierin gelöster Chlorwasserstoff die Selektivität bei der erneuten Chlorierung stört. In diesem Falle ist es vorteilhaft, die Neutralisierung mit wässriger Natronlauge vorzunehmen, da hierdurch die für die Gefrierpunktserniedrigung des Reaktionsmediums benötigte Natriumchloridmenge gebildet wird, was eine weitere Vereinfachung der Verfahrensführung ermöglicht.However, neutralization of the aqueous phase is only necessary if the process is carried out continuously and the aqueous phase is used again as a reaction medium for the chlorination, that is to say is circulated, since hydrogen chloride dissolved therein interferes with the selectivity during the renewed chlorination. In this case, it is advantageous to carry out the neutralization with aqueous sodium hydroxide solution, since this forms the amount of sodium chloride required to lower the freezing point of the reaction medium, which further simplifies the procedure.
Nach dem erfindungsgemässen Verfahren können alpha-Chlor-Monoalkylacetoacetamide mit einer Selektivität von bis zu 99,5% bei einem Umsatz von über 95,5% und in einer Ausbeute von bis zu 95,5% der Theorie, bezogen auf umgesetztes Mono-N-alkylacetoacetamid hergestellt werden, was nach den bisher bekannten Verfahren nicht möglich war. Dieses Ergebnis muss insbesondere im Hinblick auf die Tatsache als überraschend bewertet werden, dass bisher davon ausgegangen wurde, dass die Steigerung der Wassermenge in einem Alkanol enthaltenden Reaktionsmedium eine Verminderung der Selektivität und des Umsatzes zur Folge hat.According to the process according to the invention, alpha-chloro-monoalkylacetoacetamides with a selectivity of up to 99.5% with a conversion of over 95.5% and in a yield of up to 95.5% of theory, based on converted mono-N- alkylacetoacetamide are produced, which was not possible by the previously known methods. This result must be rated as surprising, particularly in view of the fact that it has previously been assumed that increasing the amount of water in a reaction medium containing alkanol results in a reduction in selectivity and conversion.
Die bei der Chlorierung verwendete Apparatur bestand aus einem emaillierten Reaktionsrührwerk mit Einleitungsrohr, Kühlmantel und Bodenauslauf, der mit einem Schauglas zur Schichtentrennung verbunden war.The apparatus used for the chlorination consisted of an enamelled reaction stirrer with an inlet tube, cooling jacket and bottom outlet, which was connected to a sight glass to separate the layers.
Das Reaktionsrührwerk wurde in der angegebenen Reihenfolge mit
- 773 Tl. Wasser,
- 227 Gew.-TI. NaCl, techn. rein, und
- 115,7 Gew.-TI. N-Methyl-acetoacetamid (MMAA), 99,5%-ig beschickt.
- 773 parts of water,
- 227 parts by weight NaCl, technical in, and
- 115.7 parts by weight N-methyl-acetoacetamide (MMAA), 99.5% charged.
In diesem Gemisch wurden unter Rühren bei -19°C bis -22°C im Verlaufe von 1 Stunde insgesamt 56,7 Gew.-TI. gasförmiges Chlor tauchend eingeleitet.In this mixture, a total of 56.7 parts by weight were stirred with stirring at -19 ° C to -22 ° C over 1 hour. gaseous chlorine is introduced by immersion.
Anschliessend wurde das erhaltene Reaktionsgemisch bei Raumtemperatur erschöpfend mit Benzol extrahiert, die Benzol-Phase der destillativen Aufarbeitung zugeführt und die wässrige Phase mit 50%-iger Natronlauge bei Raumtemperatur neutralisiert. Bei der destillativen Aufarbeitung der Benzol-Phase wurde das Benzol durch einfaches Abtreiben im Vakuum (ca. 560 mbar, erst gegen Ende des Vorgangs wurde das Vakuum auf 6,5 mbar erhöht) praktisch vollständig entfernt, wobei eine Sumpftemperatur von 85°C nicht überschritten wurde. Als Rückstand wurde dabei eine bei 78°C erstarrende Schmelze erhalten, mit folgender Zusammensetzung:
- 97,4 Gew.% N-Methyl-a-chloracetoacetamid (MMCAA)
- 2,0 Gew.% N-Methylacetoacetamid (MMAA)
- 0,6 Gew.% N-Methyl-a-a-dichloracetoacetamid (MMDCAA).
- 97.4% by weight of N-methyl-a-chloroacetoacetamide (MMCAA)
- 2.0% by weight N-methylacetoacetamide (MMAA)
- 0.6% by weight N-methyl-aa-dichloroacetoacetamide (MMDCAA).
Die neutrale, NaCI-haltige, wässrige Phase mit einem Rest-MMAA-Gehalt von 21,6 Gew.-TI. wurde erneut in das Reaktionsrührwerk eingelegt, mit 50 Tl. Wasser und 94,0 Gew.-TI. 99,5%- igem N-Methylacetoacetamid versetzt und wie oben beschrieben chloriert und aufgearbeitet.The neutral, NaCI-containing, aqueous phase with a residual MMAA content of 21.6% by weight. was again placed in the reaction stirrer, with 50 parts of water and 94.0 parts by weight. 99.5% N-methylacetoacetamide added and chlorinated and worked up as described above.
Insgesamt wurde die wässrige Phase dabei 5 mal der Chlorierung zugeführt. Es wurden insgesamt 492 Gew.-TI. N-Methylacetoacetamid (MMAA) 99,5%-ig, sowie 283,5 Gew.-TI. Chlor eingesetzt und insgesamt 588,6 Gew.-TI. 97,4%-iges N-Methyl-a-chloracetoacetamid (MMCAA) erhalten, das sind 96,8% d.Th. bezogen auf umgesetztes MMAA.In total, the aqueous phase was fed to chlorination 5 times. A total of 492 parts by weight. N-methylacetoacetamide (MMAA) 99.5% and 283.5% by weight. Chlorine used and a total of 588.6 parts by weight. Obtained 97.4% N-methyl-a-chloroacetoacetamide (MMCAA), that is 96.8% of theory based on implemented MMAA.
Im MMCAA sind noch 11,8 Gew.-TI. MMAA enthalten. Der MMAA-Umsatz betrug 95,6% und die Selektivität 99,5%. Praktisch gleiche Ergebnisse wurden erhalten, wenn anstelle von NaCl 203 Gew.-TI. CaC12 oder 163 Gew.-TI. MgCI2 eingesetzt wurden.The MMCAA still has 11.8 parts by weight. MMAA included. The MMAA conversion was 95.6% and the selectivity 99.5%. Practically the same results were obtained if instead of NaCl 203 parts by weight. CaC1 2 or 163 parts by weight MgCl 2 were used.
Das Verfahren gemäss Beispiel 1 wurde wiederholt, jedoch unter Abänderung des Molverhältnisses Chlor: MMAA. Die Ergebnisse sind in derfolgenden Tabelle I zusammengestellt:
Das Verfahren gemäss Beispiel 1 wurde wiederholt, jedoch mit der Abänderung, dass anstelle von 99,5%-igen N-Methylacetoacetamid eine wässrige 68,7%-ige Lösung eingesetzt wurde, die durch Umsetzung von Diketen mit wässrigem 40%-igem Methylamin hergestellt worden war.The procedure according to Example 1 was repeated, but with the modification that instead of 99.5% N-methylacetoacetamide, an aqueous 68.7% solution was used, which was prepared by reacting diketene with aqueous 40% methylamine had been.
Insgesamt wurden 712 Gew.-TI. einer 68,7%- igen N-Methylacetoacetamidlösung (MMAA) eingesetzt und 580,5 Gew.-TI. N-Methyl-a-chloracetoacetamid (MMCAA) von der gleichen Zusammensetzung, wie in Beispiel 1 beschrieben, erhalten. Das sind 95,5% d.Th. bezogen auf umgesetztes MMAA.A total of 712 parts by weight. a 68.7% strength N-methylacetoacetamide solution (MMAA) and 580.5 parts by weight. N-Methyl-a-chloroacetoacetamide (MMCAA) of the same composition as described in Example 1 was obtained. That is 95.5% of theory based on implemented MMAA.
Das Verfahren gemäss Beispiel 1 wurde wiederholt, jedoch mit der Abänderung, dass nach beendeter Chlorierung das Reaktionsgemisch abgekühlt und die Suspension filtriert, der dabei anfallende Feststoff mit Benzol extrahiert und der Extrakt wie in Beispiel 1 angegeben weiterbehandelt wurde. Dabei wurden als Rückstand 309,4 Gew.-TI. einer bei 80°C erstarrenden Schmelze erhalten, die reines 99,5%-iges N-Methyl-2-chloracetoacetamid (MMCAA) darstellte, das sind 52% der Theorie bezogen auf umgesetztes MMAA. Die verbleibende Mutterlauge wurde wie in Beispiel 1 beschrieben, aufgearbeitet und daraus weitere 260 Gew.-TI. MMCAA 100%-ig gerechnet, erhalten.The process according to Example 1 was repeated, but with the modification that after the chlorination had ended, the reaction mixture was cooled and the suspension was filtered, the resulting solid was extracted with benzene and the extract was further treated as indicated in Example 1. The residue was 309.4 parts by weight. a melt solidifying at 80 ° C., which was pure 99.5% N-methyl-2-chloroacetoacetamide (MMCAA), that is 52% of theory based on converted MMAA. The remaining mother liquor was worked up as described in Example 1, and from it a further 260 parts by weight. MMCAA 100% calculated, received.
Claims (4)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2824046 | 1978-06-01 | ||
| DE19782824046 DE2824046A1 (en) | 1978-06-01 | 1978-06-01 | PROCESS FOR THE PRODUCTION OF ALPHA-CHLOROACETOACETAMIDES |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| EP0005849A1 EP0005849A1 (en) | 1979-12-12 |
| EP0005849B1 EP0005849B1 (en) | 1981-10-21 |
| EP0005849B2 true EP0005849B2 (en) | 1986-07-16 |
Family
ID=6040773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP79101725A Expired EP0005849B2 (en) | 1978-06-01 | 1979-06-01 | Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4207259A (en) |
| EP (1) | EP0005849B2 (en) |
| JP (1) | JPS54157525A (en) |
| BR (1) | BR7903427A (en) |
| DE (2) | DE2824046A1 (en) |
| IL (1) | IL57174A (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL65246A (en) * | 1981-03-26 | 1985-11-29 | Lonza Ag | Process for the preparation of 2-chloroacetoacetamides |
| JPS58136993U (en) * | 1982-03-08 | 1983-09-14 | 神鋼電機株式会社 | DC non-commutator motor |
| DE3410183A1 (en) * | 1984-03-20 | 1985-09-26 | A.P.A.- Antiparassitari per Agricoltura S.p.A., Rovigo | Process for the preparation of a-chloro-N- monomethylacetoacetamide |
| ATE39478T1 (en) * | 1984-05-29 | 1989-01-15 | Ciba Geigy Ag | PROCESS FOR THE PRODUCTION OF ALPHACHLORACETETTIES|UREMONOMETHYLAMIDE. |
| DE69219768T2 (en) * | 1992-07-06 | 1997-08-28 | Societe Des Produits Nestle S.A., Vevey | Milk bacteria |
| US5442115A (en) * | 1994-06-15 | 1995-08-15 | Uniroyal Chemical Company, Inc. | Preparation of alpha-chloroacetoacetanilide compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB977213A (en) * | 1961-08-14 | 1964-12-02 | Shell Int Research | Improvements in or relating to a process for the preparation of alpha-chloro beta-oxo fatty acid amides |
| US3449421A (en) * | 1964-01-20 | 1969-06-10 | Shell Oil Co | Chlorination process |
| US3358023A (en) * | 1965-10-01 | 1967-12-12 | Shell Oil Co | Dehalogenation process to produce 2-mono-halo-acetoacetamides |
| CH472382A (en) * | 1966-02-21 | 1969-05-15 | Ciba Geigy | Partial chlorination of acetoacetic acid amides |
| FR2065067A5 (en) * | 1969-10-08 | 1971-07-23 | Shell Int Research | |
| US3852351A (en) * | 1972-10-02 | 1974-12-03 | Fmc Corp | Chlorination of acetoacetamides |
| US3917694A (en) * | 1974-04-12 | 1975-11-04 | Shell Oil Co | Chlorination of 3-oxoalkanamides |
| CH634547A5 (en) * | 1977-06-30 | 1983-02-15 | Ciba Geigy Ag | METHOD FOR PRODUCING ALPHA-MONOCHLORACETEACETIC ACIDMONOMETHYLAMIDE. |
-
1978
- 1978-06-01 DE DE19782824046 patent/DE2824046A1/en not_active Withdrawn
-
1979
- 1979-04-30 IL IL57174A patent/IL57174A/en unknown
- 1979-05-25 US US06/042,700 patent/US4207259A/en not_active Expired - Lifetime
- 1979-05-30 JP JP6630279A patent/JPS54157525A/en active Granted
- 1979-05-31 BR BR7903427A patent/BR7903427A/en unknown
- 1979-06-01 EP EP79101725A patent/EP0005849B2/en not_active Expired
- 1979-06-01 DE DE7979101725T patent/DE2961058D1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| BR7903427A (en) | 1980-01-15 |
| EP0005849B1 (en) | 1981-10-21 |
| DE2961058D1 (en) | 1981-12-24 |
| US4207259A (en) | 1980-06-10 |
| IL57174A (en) | 1982-11-30 |
| IL57174A0 (en) | 1979-07-25 |
| JPS5649901B2 (en) | 1981-11-25 |
| JPS54157525A (en) | 1979-12-12 |
| DE2824046A1 (en) | 1979-12-06 |
| EP0005849A1 (en) | 1979-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69008373T2 (en) | Process for the preparation of tetrabromobisphenol A. | |
| DE1643146A1 (en) | Process for the preparation of epsilon-caprolactones and / or 6-formyloxycaproic acids | |
| EP0005849B2 (en) | Process for preparing alpha-chloro-n-monoalkyl-acetoacetamides | |
| DE2212604B2 (en) | PROCESS FOR THE PREPARATION OF 2-HALOGENAETHYLPHOSPHONE ACIDS | |
| EP0398061B1 (en) | Method of preparing alpha-fluoroacrylic acid derivatives and 1,1-difluoro-2-halogenoethyl(halogeno)methyl-ketones | |
| DE3104310A1 (en) | METHOD FOR PRODUCING 5-CHLORINE-2-NITROANILINE | |
| EP3774749B1 (en) | Method for producing 3,4-dichloro-n-(2-cyanophenyl)-5-isothiazolecarboxamide | |
| DE69026119T2 (en) | Process for the preparation of dichloro (2,2) -paracyclophanes | |
| EP0166685B1 (en) | Process for the preparation of alpha-chloroacetoacetic-acid monomethyl amide | |
| DE60005613T2 (en) | Process for the preparation of dimethylcyanamide | |
| DE2519315C2 (en) | Process for the preparation of 3-trichloromethyl-5-chloro-1,2,4-thiadiazole | |
| DE69104782T2 (en) | Process for the production of unsaturated bromides. | |
| CH405271A (en) | Process for the preparation of 2-chloro-3-bromopropene and propargyl bromide | |
| DE954873C (en) | Process for the preparation of Diaethylisonitrosomalonate | |
| DD234000A1 (en) | PROCESS FOR THE PREPARATION OF 1,2-NAPHTHOCHINONDIAZIDE- (2) -SULPHONATE ACID CHLORIDES | |
| DE3101650A1 (en) | Process for the preparation of pure acetoacetamide which is stable on storage | |
| AT253488B (en) | Process for the preparation of 2-methyl-4-chlorophenoxyalkanoic acids | |
| DE2014783C3 (en) | Process for the separation of sulfuric acid from a reaction mixture | |
| DE2101359C3 (en) | Process for the preparation of 4-mercaptophenols | |
| DE2824558B2 (en) | Process for the production of squaric acid | |
| EP0054142B1 (en) | Process for preparing vinyl sulphonates | |
| DE2358623B1 (en) | Process for the production of chlorohydroquinone | |
| CH634547A5 (en) | METHOD FOR PRODUCING ALPHA-MONOCHLORACETEACETIC ACIDMONOMETHYLAMIDE. | |
| CH620903A5 (en) | ||
| DE2161995A1 (en) | PROCESS FOR THE PRODUCTION OF BENZOTRIFLUORIDE OR ITS DERIVATIVES |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| AK | Designated contracting states |
Designated state(s): CH DE FR GB IT NL |
|
| 17P | Request for examination filed | ||
| ITF | It: translation for a ep patent filed | ||
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| AK | Designated contracting states |
Designated state(s): CH DE FR GB IT NL |
|
| REF | Corresponds to: |
Ref document number: 2961058 Country of ref document: DE Date of ref document: 19811224 |
|
| PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
| 26 | Opposition filed |
Opponent name: FROESEL, SIEGFRIED, DR. Effective date: 19820719 |
|
| ITF | It: translation for a ep patent filed | ||
| PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
| 27A | Patent maintained in amended form |
Effective date: 19860716 |
|
| AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): CH DE FR GB IT NL |
|
| NLR2 | Nl: decision of opposition | ||
| ET3 | Fr: translation filed ** decision concerning opposition | ||
| NLR3 | Nl: receipt of modified translations in the netherlands language after an opposition procedure | ||
| ITTA | It: last paid annual fee | ||
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19970521 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19970523 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 19970527 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 19970528 Year of fee payment: 19 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19970703 Year of fee payment: 19 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980601 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980630 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990101 |
|
| GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19980601 |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990226 |
|
| NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19990101 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990401 |
|
| REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
| RDAH | Patent revoked |
Free format text: ORIGINAL CODE: EPIDOS REVO |